Potentially Harmful Antiparkinsonian Agents for Older Adults

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 6
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2024-01-23T01:10:32-05:00",
  "meta" : {
    "versionId" : "5",
    "lastUpdated" : "2024-01-23T15:47:15.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for potentially harmful antiparkinsonian agents for older adults as described in the 2023 American Geriatrics Society BEERS criteria),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable medications. Includes Benztripine and Trihexyphenidyl medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients.)",
  "name" : "PotentiallyHarmfulAntiparkinsonianAgentsForOlderAdults",
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "885209",
      "display" : "benztropine mesylate 2 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "885213",
      "display" : "benztropine mesylate 1 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "885219",
      "display" : "benztropine mesylate 0.5 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "905269",
      "display" : "trihexyphenidyl hydrochloride 2 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "905273",
      "display" : "trihexyphenidyl hydrochloride 0.4 MG/ML Oral Solution",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "905283",
      "display" : "trihexyphenidyl hydrochloride 5 MG Oral Tablet",
      "version" : "05062024"
    } ],
    "total" : 6,
    "identifier" : "urn:uuid:229cc70a-cb90-4c95-8636-4fee2e1416c7",
    "timestamp" : "2024-06-14T17:09:10-04:00"
  },
  "title" : "Potentially Harmful Antiparkinsonian Agents for Older Adults",
  "extension" : [ {
    "valueString" : "NCQA PHEMUR Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2024-01-23",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2024-01-23",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "2.16.840.1.113883.3.464.1003.1251",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1251",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.464.1003.1251"
  } ],
  "version" : "20240123"
}